Navigation Links
Human Genome Sciences Presents New Data Showing Anti-Tumor Activity And Safety Of Trail Receptor Antibodies In Combination With Chemotherapy
Date:10/24/2007

n more than 20 patients, a number of whom remained on treatment for more than five months before progression of disease."

About the Preclinical Results in Cholangiocarcinoma

Results were also presented from preclinical studies that evaluated the ability of HGS-ETR1 and HGS-ETR2 to kill cancer cells and inhibit tumor growth as single agents and in combination with chemotherapy agents: cisplatin, gemcitabine or 5-fluorouracil. Efficacy was measured using cell toxicity assays in cholangiocarcinoma cell lines (in vitro) and in a xenograft cholangiocarcinoma tumor model (in vivo).

The in vitro study showed that HGS-ETR1 or HGS-ETR2 combined with either a pre-treatment or a co-treatment chemotherapy regimen induced additive or synergistic cytotoxicity. Co-treatment with the triplet combination of cisplatin, gemcitabine and either HGS-ETR1 or HGS-ETR2 was more effective than either single agent alone in all cell lines, with most triplet combinations inducing greater than 90 percent cell toxicity. In a xenograft model of cholangiocarcinoma, the combination of HGS-ETR1, cisplatin and gemcitabine significantly inhibited tumor growth, including tumor regression observed at a dose of 8 mg/kg of cisplatin.

About the HGS TRAIL Receptor Antibodies

HGS-ETR1 and HGS-ETR2 are agonistic human monoclonal antibodies that directly induce cancer-cell death by specifically binding to and activating the proteins known as TRAIL receptors 1 and 2, respectively. Using genomic techniques, HGS originally identified the TRAIL receptor-1 and TRAIL receptor- 2 proteins. The HGS-ETR1 and HGS-ETR2 antibodies were generated by HGS through collaboration with Cambridge Antibody Technology. HGS is developing HGS-ETR1 and HGS-ETR2 as potential treatments for a broad range of cancers.

GlaxoSmithKline (GSK) has exercised its option under a June 1996 agreement to develop and commercialize HGS-ETR1 jointly with HGS. Under the terms of the agreement, GSK and HGS will share e
'/>"/>

SOURCE Human Genome Sciences, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. Testing for Human Papillomavirus
2. Bio-Matrix Scientifics Dr. ONeill Sees University of Pittsburghs Published Study on Culture Blood-Forming Stem Cells from Human Fat Tissue as Supporting Near Term Benefits of Banking Adipose (Fat) Derived Stem Cells
3. Phase II Results Show Once-Daily Dosing of Human GLP-1 Analog Liraglutide, Brings Patients to A1c Target
4. Apollos human proteins boost stem cell research
5. Advanced Cell Technology Develops First Human Embryonic Stem Cell Line without Destroying an Embryo
6. Modigene Announces Successful Completion of Pharmacokinetic & Pharmacodynamic Pre-Clinical Experiments for Proprietary Long-Acting Human Growth Hormone, Long-acting Interferon Beta and Long-acting Erythropoietin
7. Second Successful Quigley QR-443 Study Suggests Method of Action Relevant to Broad Range of Chronic Inflammatory Diseases - Human Study to Follow -
8. Research Documents Scalable Production, Survival Following Engraftment and Positive Impact on Cardiac Function in Infarcted Rats for Gerons Human Embryonic Stem Cell-Based Therapeutic for Heart Failure
9. Human Genome Sciences Reports That a Phase 2 Study of LymphoStat-B Showed Significant Reductions in Disease Activity in Patients with Active Systemic Lupus Erythematosus
10. NCI Researchers Discover Genes That Are Turned on at High Levels in Tumor-associated Blood Vessels of Mice and Humans
11. Research Indicates Gerons Human Embryonic Stem Cell-Based Therapeutic for Spinal Cord Injury Evades Direct Attack by the Human Immune System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2009)... to Fix the Bill ,, WASHINGTON, Dec. ... Coalition for a Competitive Pharmaceutical Market (CCPM) will ... and in select states charging that, during this ... gift of all to brand pharmaceutical companies" by ... ads urge the President to tell Congress to ...
(Date:12/17/2009)... PALM CITY, Fla., Dec, 17 Connectyx ... today that it has formed a distribution partnership ... Order distributor of Diabetic Supplies, Respiratory Supplies and ... the VED Erectile Dysfunction System. ,, Terms of ... Ronn Schuman stated that, "This partnership adds to ...
(Date:12/17/2009)... Dec. 17 Frost & Sullivan ... American Healthcare Innovation Award in molecular diagnostics ... its commitment to providing innovative technologies for ... its incorporation in 2004, IntelligentMDx has introduced ... to make tests that are clinically impactful, ...
Breaking Medicine Technology:Coalition for a Competitive Pharmaceutical Market Runs Ads Stating Congress Is Giving 'Greatest Holiday Gift of All to Brand Pharmaceutical Companies' 2Coalition for a Competitive Pharmaceutical Market Runs Ads Stating Congress Is Giving 'Greatest Holiday Gift of All to Brand Pharmaceutical Companies' 3Connectyx Announces Distribution Partnership with United States Medical Supply 2Connectyx Announces Distribution Partnership with United States Medical Supply 3Frost & Sullivan Recognizes IntelligentMDx for Its Commitment to the Advancement of Healthcare and Diagnostics 2Frost & Sullivan Recognizes IntelligentMDx for Its Commitment to the Advancement of Healthcare and Diagnostics 3Frost & Sullivan Recognizes IntelligentMDx for Its Commitment to the Advancement of Healthcare and Diagnostics 4Frost & Sullivan Recognizes IntelligentMDx for Its Commitment to the Advancement of Healthcare and Diagnostics 5Arizona Pain Specialists Contend Recent Vertebroplasty Studies are Misleading 3A Studies Actually Show it is Effective at Reducing Pain 53944 1Arizona Pain Specialists Contend Recent Vertebroplasty Studies are Misleading 3A Studies Actually Show it is Effective at Reducing Pain 53944 2Arizona Pain Specialists Contend Recent Vertebroplasty Studies are Misleading 3A Studies Actually Show it is Effective at Reducing Pain 53944 3Hospice Partners On Call Selects Category 5 Hurricane Rated 1Vault Networks to Safeguard Server and Call Center Infrastructure 53942 1Hospice Partners On Call Selects Category 5 Hurricane Rated 1Vault Networks to Safeguard Server and Call Center Infrastructure 53942 2FDA Approves New 3000 IU Vial Size for Kogenate 28R 29 FS antihemophilic factor 28recombinant 29 53939 1FDA Approves New 3000 IU Vial Size for Kogenate 28R 29 FS antihemophilic factor 28recombinant 29 53939 2FDA Approves New 3000 IU Vial Size for Kogenate 28R 29 FS antihemophilic factor 28recombinant 29 53939 3FDA Approves New 3000 IU Vial Size for Kogenate 28R 29 FS antihemophilic factor 28recombinant 29 53939 4
(Date:12/17/2009)... 17 On the heels of unveiling the ... the 2010 race, LA Marathon officials today announced a ... raising funds for causes ranging from cancer research to ... expanded charity program is in line with the vision ... has the potential to be a huge philanthropic force ...
(Date:12/17/2009)... /PRNewswire-Asia/ -- China,s leading high-tech,healthcare group, Golden Meditech ... 801) is pleased to announce today the interim ... review, the Group,s two,associate companies made their debut ... key businesses have been strengthened, with maiden revenue ... , Mr. KAM Yuen, ...
(Date:12/17/2009)... Jay and Maureen Neitz, the husband-and-wife team whose pioneering ... to treat vision disorders, as the inaugural recipients of ... The award is funded by a $1 million endowment ... Jay Pepose ,75 and Susan K. Feigenbaum ,74, his ... vision science. , The Neitzes, both of whom are ...
(Date:12/17/2009)... need to monitor cell phone use in era of ... 17 (HealthDay News) -- Teens and preteens spend hours ... content of some of those messages -- sexually explicit ... causing growing concern among parents, University of Michigan researchers ... that 41 percent of parents are worried about the ...
(Date:12/17/2009)... firm’s Interim Leadership division as senior vice president. A seasoned executive ... assume her duties at B. E. Smith today. , ... ... Smith recently hired Deirdre Byrne to lead the firm’s Interim ... 20 years of experience in healthcare consulting, Byrne will assume her ...
Breaking Medicine News(10 mins):Health News:LA Marathon Unveils Expanded Charity Program; Sixty Official Charities to Take Part in 2010 Race 2Health News:LA Marathon Unveils Expanded Charity Program; Sixty Official Charities to Take Part in 2010 Race 3Health News:LA Marathon Unveils Expanded Charity Program; Sixty Official Charities to Take Part in 2010 Race 4Health News:Golden Meditech Announces Interim Results of FY2009/10 2Health News:Golden Meditech Announces Interim Results of FY2009/10 3Health News:Vision researchers Jay and Maureen Neitz to receive first Pepose Award from Brandeis 2Health News:'Sexting' by Kids Begets Fretting by Parents 2Health News:Deirdre Byrne Joins B. E. Smith as Senior Vice President, Interim Leadership Services 2Health News:Deirdre Byrne Joins B. E. Smith as Senior Vice President, Interim Leadership Services 3
... technique allowing doctors to operate on patients by ... potentially replace certain types of conventional surgery in ... have successfully demonstrated the procedure in pigs. , ... trials, researchers say it could circumvent the long ...
... Kate Weber, registered dietician, certified personal trainer, marathoner, and wellness enthusiast ... to live a better, longer, healthier and younger ... ... Dec. 17 be, better nutrition for active,lifestyles available exclusively at ...
... ... Procedures, CLEVELAND, Dec. ... Software, announced today that,it has donated over $71,000 in software to ... improve lives,worldwide through research, education, and services in family health. FHI,will ...
... at UCLA and NanoPacific Holdings Inc. have announced a ... lead to prolonged lives of enhanced quality for millions ... terms of the partnership, NanoPacific will receive exclusive license ... at the CNSI,s Nano Machine Center. The newly formed ...
... 17 ULURU Inc. (Amex:,ULU) today announced that ... the,United States Patent and Trademark Office for its ... science behind the Company,s,nanoparticle aggregate technology; consequently, this ... Commenting on the issuance of the Notice ...
... CSG/SportsCoatings,today announced a major deal that brings ... to 25 high schools in,Virginia,s Fairfax County ... is the model for how schools and ... minimizing prevalent,bacterial issues like staph and MRSA," ...
Other Medicine News:Health News:Z-shaped incision enhances minimally invasive surgery 2Health News:Z-shaped incision enhances minimally invasive surgery 3Health News:be(R) is Making Health Simple With Complimentary, Expert Online Diet, Nutrition and Exercise Advice 2Health News:IQS Donates Quality Management Software to Family Health International 2Health News:IQS Donates Quality Management Software to Family Health International 3Health News:UCLA-industry partnership to develop, commercialize new nanotechnology 2Health News:UCLA-industry partnership to develop, commercialize new nanotechnology 3Health News:ULURU Inc. Announces Issuance of Notice of Allowance for Nanoparticle Aggregate Patent 2Health News:Virginia School District Gets Proactive Against MRSA 2
... Diagnostics is a leading provider of immunofluorescence ... test menu that includes kits for autoimmune ... as miscellaneous conjugates and components. Our Impact ... assortment of substrates and kit sizes to ...
... Inverness Medical Professional Diagnostics is a leading ... IFA and DFA test menu that includes ... STDs as well as miscellaneous conjugates and ... you a wide assortment of substrates and ...
... Inverness Medical Professional Diagnostics is a ... extensive IFA and DFA test menu that ... and STDs as well as miscellaneous conjugates ... give you a wide assortment of substrates ...
... disease ELISA products make us a leader ... for faster integration into the busy laboratory, ... reliability and run-to-run consistency. Our Infectious Disease ... a wide range of serological assays including ...
Medicine Products: